The p21 gene encodes a cyclin dependent kinase inhibitor protein (p21) whic
h has a tumor suppressive activity in a variety of tumor cell lines. Since,
the p21 gene is up-regulated by the p53 tumor suppressor gene, which is fr
equently mutated in gliomas, acting therefore in the same control pathway,
it constitutes a good candidate gene to be also inactivated in these tumors
. To test this hypothesis, DNAs from 81 gliomas (48 glioblastomas, 11 anapl
astic astrocytomas, 10 low-grade astrocytomas, 12 oligodendrogliomas and mi
xed gliomas), were investigated for mutations in the p21 coding sequence by
denaturant gradient gel electrophoresis followed by sequencing. All these
tumors have been previously screened for p53 mutations. Three different DNA
variants were identified on codon 31 (17 cases),27 (1 case) and 117 (1 cas
e) and shown to be also present in matching constitutional DNA, suggesting
they were polymorphisms. None of the tumors demonstrated a somatic mutation
: No significant correlation between the presence of a p21 variant and the
p53 mutation tumor status was observed. In conclusion, mutation in the p21
gene unlikely contributes to the development of gliomas.